ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 110 filers reported holding ATHIRA PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,672 | -31.5% | 33,501 | 0.0% | 0.01% | -22.2% |
| Q2 2023 | $98,828 | +18.0% | 33,501 | 0.0% | 0.01% | +28.6% |
| Q1 2023 | $83,753 | -21.1% | 33,501 | 0.0% | 0.01% | -22.2% |
| Q4 2022 | $106,198 | +7.3% | 33,501 | +0.0% | 0.01% | 0.0% |
| Q3 2022 | $99,000 | -2.9% | 33,500 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $102,000 | -77.4% | 33,500 | 0.0% | 0.01% | -73.5% |
| Q1 2022 | $452,000 | +26.3% | 33,500 | +21.8% | 0.03% | +30.8% |
| Q4 2021 | $358,000 | – | 27,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
| VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
| ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
| Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
| Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
| Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
| DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
| PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
| Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
| RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |